Crossref Citations
This Book has been
cited by the following publications. This list is generated based on data provided by Crossref.
Coldman, Andrew J.
and
Murray, J.M.
2000.
Optimal control for a stochastic model of cancer chemotherapy.
Mathematical Biosciences,
Vol. 168,
Issue. 2,
p.
187.
Carpinteiro, Alexander
Peinert, Stefan
Ostertag, Wolfram
Zander, Axel R.
Hossfeld, Dieter K.
Kühlcke, Klaus
Eckert, Hans‐Georg
Baum, Christopher
and
Hegewisch‐Becker, Susanna
2002.
Genetic protection of repopulating hematopoietic cells with an improved MDR1‐retrovirus allows administration of intensified chemotherapy following stem cell transplantation in mice.
International Journal of Cancer,
Vol. 98,
Issue. 5,
p.
785.
Westman, J.J.
2003.
Cancer treatment and control.
Vol. 3,
Issue. ,
p.
3030.
Roschke, Anna V.
Lababidi, Samir
Tonon, Giovanni
Gehlhaus, Kristen S.
Bussey, Kimberly
Weinstein, John N.
and
Kirsch, Ilan R.
2005.
Karyotypic “state” as a potential determinant for anticancer drug discovery.
Proceedings of the National Academy of Sciences,
Vol. 102,
Issue. 8,
p.
2964.
2005.
Resorcinol.
p.
633.
Westman, John J.
Fabijonas, Bruce R.
Kern, Daniel L.
and
Hanson, Floyd B.
2006.
Stochastic Theory and Control.
Vol. 280,
Issue. ,
p.
491.
Schinazi, Rinaldo B.
2006.
The probability of treatment induced drug resistance.
Acta Biotheoretica,
Vol. 54,
Issue. 1,
p.
13.
Karev, Georgy P
Novozhilov, Artem S
and
Koonin, Eugene V
2006.
Mathematical modeling of tumor therapy with oncolytic viruses: effects of parametric heterogeneity on cell dynamics.
Biology Direct,
Vol. 1,
Issue. 1,
Sherer, Eric
Hannemann, Robert E.
Rundell, Ann
and
Ramkrishna, Doraiswami
2007.
Estimation of Likely Cancer Cure Using First- and Second-Order Product Densities of Population Balance Models.
Annals of Biomedical Engineering,
Vol. 35,
Issue. 6,
p.
903.
Loeb, Lawrence A.
Bielas, Jason H.
and
Beckman, Robert A.
2008.
Cancers Exhibit a Mutator Phenotype: Clinical Implications.
Cancer Research,
Vol. 68,
Issue. 10,
p.
3551.
Clairambault, J.
2009.
Modelling Physiological and Pharmacological Control on Cell Proliferation to Optimise Cancer Treatments.
Mathematical Modelling of Natural Phenomena,
Vol. 4,
Issue. 3,
p.
12.
Komarova, Natalia L.
and
Wodarz, Dominik
2009.
Combination Therapies against Chronic Myeloid Leukemia: Short-term versus Long-term Strategies.
Cancer Research,
Vol. 69,
Issue. 11,
p.
4904.
Komarova, Natalia L.
Katouli, Allen A.
Wodarz, Dominik
and
Seoighe, Cathal
2009.
Combination of Two but Not Three Current Targeted Drugs Can Improve Therapy of Chronic Myeloid Leukemia.
PLoS ONE,
Vol. 4,
Issue. 2,
p.
e4423.
Tomasetti, Cristian
and
Levy, Doron
2010.
Role of symmetric and asymmetric division of stem cells in developing drug resistance.
Proceedings of the National Academy of Sciences,
Vol. 107,
Issue. 39,
p.
16766.
Yeang, Chen-Hsiang
2010.
An integrated analysis of molecular aberrations in NCI-60 cell lines.
BMC Bioinformatics,
Vol. 11,
Issue. 1,
2011.
Mathematical modeling of cyclic treatments of chronic myeloid leukemia.
Mathematical Biosciences and Engineering,
Vol. 8,
Issue. 2,
p.
289.
Katouli, Allen A.
and
Komarova, Natalia L.
2011.
The Worst Drug Rule Revisited: Mathematical Modeling of Cyclic Cancer Treatments.
Bulletin of Mathematical Biology,
Vol. 73,
Issue. 3,
p.
549.
Li, Xiangfang
Qian, Lijun
Bittner, Michale L.
and
Dougherty, Edward R.
2012.
A Systems Biology Approach in Therapeutic Response Study for Different Dosing Regimens—a Modeling Study of Drug Effects on Tumor Growth using Hybrid Systems.
Cancer Informatics,
Vol. 11,
Issue. ,
p.
CIN.S8185.
Tomasetti, Cristian
2012.
On the Probability of Random Genetic Mutations for Various Types of Tumor Growth.
Bulletin of Mathematical Biology,
Vol. 74,
Issue. 6,
p.
1379.
Bozic, Ivana
Reiter, Johannes G
Allen, Benjamin
Antal, Tibor
Chatterjee, Krishnendu
Shah, Preya
Moon, Yo Sup
Yaqubie, Amin
Kelly, Nicole
Le, Dung T
Lipson, Evan J
Chapman, Paul B
Diaz, Luis A
Vogelstein, Bert
and
Nowak, Martin A
2013.
Evolutionary dynamics of cancer in response to targeted combination therapy.
eLife,
Vol. 2,
Issue. ,